Papa, Alfredo <br/><br/>
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.  [electronic resource] 

 -  Journal of Crohn's & colitis  Mar 2013 
 - 113-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1016/j.crohns.2012.03.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adolescent<br/>Adult<br/>Age Factors<br/>Analysis of Variance<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Colitis, Ulcerative--diagnosis<br/>Crohn Disease--diagnosis<br/>DNA, Viral--blood<br/>Female<br/>Hepacivirus--immunology<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B Vaccines<br/>Hepatitis B virus--immunology<br/>Hepatitis B, Chronic--epidemiology<br/>Hepatitis C Antibodies--blood<br/>Hepatitis C, Chronic--epidemiology<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Prevalence<br/>RNA, Viral--blood<br/>ROC Curve<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult